RNA is currently covered by 3 analysts with an average price target of $22.5. This is a potential upside of $15.58 (225.14%) from yesterday's end of day stock price of $6.92.
Avidity Biosciences's activity chart (see below) currently has 4 price targets and 8 ratings on display. The stock rating distribution of RNA is 80% BUY and 20% HOLD.
Highest price target for RNA is $25, Lowest price target is $20, average price target is $22.5.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 28-Oct-2026. First documented stock forecast 09-Nov-2023.
Currently out of the existing stock ratings of RNA, 1 are a HOLD (20%), 4 are a BUY (80%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Aug-2026
$20
$13.08 (189.02%)
$25
25 days ago
(28-Oct-2026)
0/3 (0%)
$11.6 (138.10%)
Buy Since 09-Nov-2023
$25
$18.08 (261.27%)
$18
6 months 7 days ago
(15-May-2026)
0/2 (0%)
$11.77 (88.96%)
Hold Since 01-May-2026
$72
6 months 21 days ago
(01-May-2026)
0/2 (0%)
$72 (0.00%)
Which analyst most recently updated their price target on RNA (Avidity Biosciences)?
Which analyst has the lowest performance score on RNA (Avidity Biosciences) with a proven track record?
Which analyst has the most public recommendations on RNA (Avidity Biosciences)?
Which analyst is the currently most bullish on RNA (Avidity Biosciences)?
Which analyst is the currently most reserved on RNA (Avidity Biosciences)?